Diabetes diagnosed in adults is a highly heterogeneous disorder. It mostly consists of what is referred to as type 2 diabetes but also comprises other entities (i.e different diseases), including latent autoimmune diabetes, late onset forms of monogenic diabetes and familial diabetes of the adulthood, which has recently been the source of new diabetogenes discovery. Notably, type 2 diabetes is itself heterogeneous as it includes subtypes with onset at the extremes of age and/or weight distributions characterized by different degree of hyperglycemia and cardiovascular risk as compared to common forms of type 2 diabetes occurring in middle-aged, overweight/obese individuals. Understanding whether these are different presentations of one, highly heterogeneous disease or separate nosological entities with different clinical trajectories and requiring different treatments is essential to effectively pursue the path of precision medicine.

Disentangling the heterogeneity of adulthood-onset non-autoimmune diabetes: a little closer but lot more to do / Trischitta, V.; Prudente, S.; Doria, A.. - In: CURRENT OPINION IN PHARMACOLOGY. - ISSN 1471-4892. - 55:(2020), pp. 157-164. [10.1016/j.coph.2020.10.020]

Disentangling the heterogeneity of adulthood-onset non-autoimmune diabetes: a little closer but lot more to do

Trischitta V.
;
Prudente S.;
2020

Abstract

Diabetes diagnosed in adults is a highly heterogeneous disorder. It mostly consists of what is referred to as type 2 diabetes but also comprises other entities (i.e different diseases), including latent autoimmune diabetes, late onset forms of monogenic diabetes and familial diabetes of the adulthood, which has recently been the source of new diabetogenes discovery. Notably, type 2 diabetes is itself heterogeneous as it includes subtypes with onset at the extremes of age and/or weight distributions characterized by different degree of hyperglycemia and cardiovascular risk as compared to common forms of type 2 diabetes occurring in middle-aged, overweight/obese individuals. Understanding whether these are different presentations of one, highly heterogeneous disease or separate nosological entities with different clinical trajectories and requiring different treatments is essential to effectively pursue the path of precision medicine.
2020
heterogeneity of type 2 diabetes; maturity-onset-diabetes of the young; mitochondrial diabetes; familial diabetes of the adulthood
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Disentangling the heterogeneity of adulthood-onset non-autoimmune diabetes: a little closer but lot more to do / Trischitta, V.; Prudente, S.; Doria, A.. - In: CURRENT OPINION IN PHARMACOLOGY. - ISSN 1471-4892. - 55:(2020), pp. 157-164. [10.1016/j.coph.2020.10.020]
File allegati a questo prodotto
File Dimensione Formato  
Trischitta_Disentangling_2020.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 394.3 kB
Formato Adobe PDF
394.3 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1540755
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact